Cargando…
Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes
OBJECTIVE: The mechanistic basis for the breakdown of T-cell tolerance in type 1 diabetes is unclear and could result from a gain of effector function and/or loss of regulatory function. In humans, the CD4+CD25+Foxp3+ T–cell compartment contains both effector and regulatory T cells, and it is not kn...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142074/ https://www.ncbi.nlm.nih.gov/pubmed/21715555 http://dx.doi.org/10.2337/db10-1661 |
_version_ | 1782208789202599936 |
---|---|
author | Hughson, Angela Bromberg, Irina Johnson, Barbara Quataert, Sally Jospe, Nicholas Fowell, Deborah J. |
author_facet | Hughson, Angela Bromberg, Irina Johnson, Barbara Quataert, Sally Jospe, Nicholas Fowell, Deborah J. |
author_sort | Hughson, Angela |
collection | PubMed |
description | OBJECTIVE: The mechanistic basis for the breakdown of T-cell tolerance in type 1 diabetes is unclear and could result from a gain of effector function and/or loss of regulatory function. In humans, the CD4+CD25+Foxp3+ T–cell compartment contains both effector and regulatory T cells, and it is not known how their relative proportions vary in disease states. RESEARCH DESIGN AND METHODS: We performed a longitudinal study of CD4+CD25+ T–cell function in children with type 1 diabetes at onset and throughout the 1st year of disease. Function was assessed using single-cell assays of proliferation, cytokine production, and suppression. Type 1 diabetic individuals were compared with age-matched control subjects, and suppression was directly assessed by coculture with control T–cell targets. RESULTS: We identify novel functional changes within the type 1 diabetes CD4+CD25+ compartment. Type 1 diabetic CD4+CD25+ cells exhibited a striking increase in proliferative capacity in coculture with CD4 T cells that was present at onset and stable 9–12 months from diagnosis. Elevated type 1 diabetes CD4+CD25+ cell proliferation correlated with increased inflammatory cytokines interleukin 17 and tumor necrosis factor-α but not γ-interferon. Type 1 diabetes CD4+CD25+ cytokine production occurred coincident with suppression of the same cytokines in the control targets. Indeed, enhanced proliferation/cytokines by CD4+CD25+ cells was uncoupled from their suppressive ability. Longitudinally, we observed a transient defect in type 1 diabetes CD4+CD25+ suppression that unexpectedly correlated with measures of improved metabolic function. CONCLUSIONS: Type 1 diabetes onset, and its subsequent remission period, is associated with two independent functional changes within the CD4+CD25+ T–cell compartment: a stable increase in effector function and a transient decrease in regulatory T–cell suppression. |
format | Online Article Text |
id | pubmed-3142074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-31420742012-08-01 Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes Hughson, Angela Bromberg, Irina Johnson, Barbara Quataert, Sally Jospe, Nicholas Fowell, Deborah J. Diabetes Immunology and Transplantation OBJECTIVE: The mechanistic basis for the breakdown of T-cell tolerance in type 1 diabetes is unclear and could result from a gain of effector function and/or loss of regulatory function. In humans, the CD4+CD25+Foxp3+ T–cell compartment contains both effector and regulatory T cells, and it is not known how their relative proportions vary in disease states. RESEARCH DESIGN AND METHODS: We performed a longitudinal study of CD4+CD25+ T–cell function in children with type 1 diabetes at onset and throughout the 1st year of disease. Function was assessed using single-cell assays of proliferation, cytokine production, and suppression. Type 1 diabetic individuals were compared with age-matched control subjects, and suppression was directly assessed by coculture with control T–cell targets. RESULTS: We identify novel functional changes within the type 1 diabetes CD4+CD25+ compartment. Type 1 diabetic CD4+CD25+ cells exhibited a striking increase in proliferative capacity in coculture with CD4 T cells that was present at onset and stable 9–12 months from diagnosis. Elevated type 1 diabetes CD4+CD25+ cell proliferation correlated with increased inflammatory cytokines interleukin 17 and tumor necrosis factor-α but not γ-interferon. Type 1 diabetes CD4+CD25+ cytokine production occurred coincident with suppression of the same cytokines in the control targets. Indeed, enhanced proliferation/cytokines by CD4+CD25+ cells was uncoupled from their suppressive ability. Longitudinally, we observed a transient defect in type 1 diabetes CD4+CD25+ suppression that unexpectedly correlated with measures of improved metabolic function. CONCLUSIONS: Type 1 diabetes onset, and its subsequent remission period, is associated with two independent functional changes within the CD4+CD25+ T–cell compartment: a stable increase in effector function and a transient decrease in regulatory T–cell suppression. American Diabetes Association 2011-08 2011-07-18 /pmc/articles/PMC3142074/ /pubmed/21715555 http://dx.doi.org/10.2337/db10-1661 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Immunology and Transplantation Hughson, Angela Bromberg, Irina Johnson, Barbara Quataert, Sally Jospe, Nicholas Fowell, Deborah J. Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes |
title | Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes |
title_full | Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes |
title_fullStr | Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes |
title_full_unstemmed | Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes |
title_short | Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes |
title_sort | uncoupling of proliferation and cytokines from suppression within the cd4+cd25+foxp3+ t–cell compartment in the 1st year of human type 1 diabetes |
topic | Immunology and Transplantation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142074/ https://www.ncbi.nlm.nih.gov/pubmed/21715555 http://dx.doi.org/10.2337/db10-1661 |
work_keys_str_mv | AT hughsonangela uncouplingofproliferationandcytokinesfromsuppressionwithinthecd4cd25foxp3tcellcompartmentinthe1styearofhumantype1diabetes AT brombergirina uncouplingofproliferationandcytokinesfromsuppressionwithinthecd4cd25foxp3tcellcompartmentinthe1styearofhumantype1diabetes AT johnsonbarbara uncouplingofproliferationandcytokinesfromsuppressionwithinthecd4cd25foxp3tcellcompartmentinthe1styearofhumantype1diabetes AT quataertsally uncouplingofproliferationandcytokinesfromsuppressionwithinthecd4cd25foxp3tcellcompartmentinthe1styearofhumantype1diabetes AT jospenicholas uncouplingofproliferationandcytokinesfromsuppressionwithinthecd4cd25foxp3tcellcompartmentinthe1styearofhumantype1diabetes AT fowelldeborahj uncouplingofproliferationandcytokinesfromsuppressionwithinthecd4cd25foxp3tcellcompartmentinthe1styearofhumantype1diabetes |